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Brain Image Data Acquisition
PET images were acquired 90-110 minutes after intravenous injection of 300 MBq ± 20% florbetaben (5) according to a standardized acquisition and image-processing protocol established during a technical visit to each center. Three-dimensional volumetric T1weighted brain MRI (e.g. magnetization prepared rapid gradient echo or spoiled gradient recalled sequences) were collected.
Study design
Florbetaben scans were assessed visually and quantitatively, and results compared with β -amyloid presence/absence in pathology. For visual assessment, either in-person training (n=3 expert readers) or an electronic training (e-training) method (n=5 naïve readers) was used. Composite standardized uptake value ratios (SUVRs) were determined (6) , and receiver operating characteristic curve analysis used to ascertain the optimal threshold for the sensitivity/specificity calculations. The composite SUVR providing the highest sum of sensitivity and specificity was selected as cut-off value.
Visual assessment method
The in-person expert training and electronic training modules were identical in approach and content (6, 7) . The training emphasized normal white matter anatomy using structural MRI and coregistered florbetaben PET images to appreciate white matter -gray matter boundaries since a positive scan demonstrates extension of radiotracer uptake beyond the cortical white matter to adjacent gray matter in key brain regions. Specifically, readers used a regional cortical tracer uptake scoring system (RCTU) (1 = no tracer uptake, 2 = moderate tracer uptake, 3 = pronounced tracer uptake) in four brain areas: lateral temporal cortex, frontal cortex, posterior cingulate cortex/precuneus, parietal cortex (see figure 1 for details). The resulting scores condense into a binary interpretation (score 1 = negative; score 2 or 3 = positive). A RCTU score of 1 in each brain region led to a brain amyloid plaque load (BAPL) score of 1, a RCTU score of 2 in any brain region and no score 3 led to a BAPL score of 2. A RCTU score of 3 in any of the 4 brain regions led to a BAPL of 3.
No access to other scan orientations (i.e. coronal, sagittal), and no reorientation or structural information from computed tomography (CT) or magnetic resonance imaging (MRI) was available to readers. Readers viewed scans in gray scale only. There were some minor differences between the training, as the trainees could not ask questions of an expert reader during the review with the electronic training tool.
All images were assessed by eight readers: three in-person trained experts and five naïve readers trained using an e-training tool. All readers were nuclear medicine physicians.
The "expert reader" was defined as having direct experience with PET amyloid scans. The naïve reader had no experience with the visual assessment method and was not involved in any pivotal study using an 18F-labeled amyloid imaging agent.
Quantitative assessment method
Brain PET image quantification was performed using a standardized volume of interest template applied to the spatially normalized grey matter PET image based on a gray/white/cerebrospinal fluid segmentation of the participant's T1-weighted volumetric MRI (6) . A region of interest template (6) sampled the lateral temporal, frontal, anterior and posterior cingulate gyrus/precuneus, and parietal lobes which were averaged to determine a composite SUVRs calculated using the cerebellar cortex as the reference tissue. 81 of the 82 brains were evaluated in this fashion; in one scan the segmentation process failed owing to poor technical quality of the MRI. (8), providing a semi-quantitative score with the categories "absent", "sparse", "moderate", or "frequent". The same semi-quantitative categories were used to score the number of cored plaques detected by β -amyloid immunohistochemistry. β amyloid was regarded as present in a given brain region when sufficient neuritic or cored plaques were present to achieve a score of "moderate" or "frequent".
Pathology standard of truth
Importantly, BSS is not specific for β -amyloid deposits and also has some technical limitations that may hinder the identification of some neuritic plaques in AD (9) . The combination of BSS and immunohistochemistry for β -amyloid is recommended in current neuropathologic guidelines for assessment of AD pathology (10, 11) . Therefore, both BSS and BSS+immunohistochemistry data were used for further analyses.
Statistical analysis
Sensitivity, specificity and accuracy were evaluated by comparing visual assessments 
Inter-and intra-reader agreement
Inter-reader agreement (Fleiss' kappa) was 0.89 (considered excellent, 95%
confidence interval [CI]: 0.82, 0.97) for expert in-person-trained readers and 0.71 (considered very good, 95% CI: 0.62, 0.81) for naïve e-trained readers ( Table 2 ). Median (range) intrareader agreement was 0.9 (0.79-0.90) for expert in-person trained readers and 0.9 (0.66-1.00) for e-trained readers ( Table 3 ). Table 4 , Figure 2A ). Similarly, for in-person trained readers; 88.9% (n=72) of assessments were concordant and 11.1% (n=9) were discordant with quantitation, with significant relationship between methods (Χ 2 = 47.33, p<0.0001, Kappa = 0.76; Table 5 , Figure 2B ).
Comparison of visual and quantitative assessments
Further details of the 10 discordant cases are summarized in Table 6 . Concordance with the pathology results was found with visual assessment in 9 cases by in-person trained readers, in 8 cases by e-trained readers, but with the quantitative assessment only 2 cases matched the pathology results. Marked atrophy was found in 7 cases, all with visual assessment matching pathology results (6 positive and one negative case). However, for the 7 marked atrophy cases none of the quantitative assessment results matched with pathology,
showing SUVRs < 1.47 in the 6 positive cases and SUVR of 1.52 in the negative case with marked atrophy. Reader agreement for 8 of 10 cases was very high both for the in-person and electronically trained reader groups. Only for one subject (case # 75 in table 6, supplementary table 1) the visual assessments did differ for the two methods.
Challenging cases
The patient cohort included challenging cases, such as subjects with marked brain atrophy or scans with head motion. Indeed, BSS+immunohistochemistry is recommended in current neuropathological guidelines for assessment of AD pathology (10, 11) . Intra-reader and inter-reader agreement was very high for both training groups.
The individual differences in sensitivity and specificity amongst the five inexperienced readers are particularly informative. There was a wide range of specificity in particular, with two readers showing relatively lower performance than the other three. Post-study interviews with each individual reader suggested that those with poorer performance were less rigid in the application of the training rules to their visual assessments. Specifically, when assessing whether a particular region is positive, the algorithm requires that the majority (i.e. at least 50%) of the axial slices comprising each region must be positive. In some instances, the poorer readers did not apply this rule systematically, leading to a region being classified as positive. Nonetheless, the sensitivity and specificity in the present study were consistent with earlier analyses from the same study (3) The relationship of visual reads to quantitative values was also consistent with prior reports (6, 14) , indicating high concordance between visual positivity and negativity and the composite SUVR using a quantitative cut-off for positive and negative scans. There were only few cases (10 for e-trained and 9 for in-person trained out of 81 case evaluations) in which there was discordance between visual and quantitative assessments. The visual assessment method used did not allow comparison of the PET scan images with CT or MR.
This may lead to difficulties in the interpretation of some cases with atrophy, and quantification could potentially help here. Most of the visual vs quantitative discordant cases showed marked atrophy. However, in this study the visual assessment of discordant cases matched with pathology results. Quantitative assessment of cases with marked atrophy were all discordant with pathology results. The readers were more adept at distinguishing gray matter from white matter uptake in scans with severe atrophic changes than the quantification method. Two exceptions to this are shown in figures 1 and 2 in the supplementary material.
This suggests that atrophy may affect the quantification method used in this study more than the visual assessment. Further investigation is required to substantiate this and whether partial volume error correction influences this result.
The end-of-life population used in this study is not the intended population for β amyloid PET scanning. The clinically intended population will likely have less structural brain abnormalities observed in this study cohort. Furthermore, the reading methodology designed for florbetaben in the present study was quite restrictive, with readers not permitted to use all the tools routinely available in nuclear medicine for PET assessment (3). In clinical practice, PET scans are read using three spatial orientations, with structural images provided by CT or MRI to guide anatomical localization of findings, often in discontinuous color scales for fused images. Additional use of all available tools for image reading will likely increase the diagnostic performance. Nevertheless, excellent results were obtained even allowing for the challenging nature of some scans and the stringent requirements of the applied reading methodology.
Overall, visual assessment of florbetaben images was robust even in challenging scans from elderly end-of-life individuals. Sensitivity and specificity were high, as was inter-reader agreement, independent of the reader expertise and training method employed. The visual assessment strategy and respective training tools to analyze florbetaben PET scans are accurate and reliable in the detection of brain neuritic β -amyloid plaques as assessed using BSS, and cored plaques as assessed using immunohistochemistry, and showed a good correlation with quantitative assessments. 
